CEACAM5 and neoplasm: Surface antigens, such as galactoagglutinin-3 and carcinoembryonic antigen [182], specifically expressed by tumor cells have a structural domain that allows adhesion to homologous cells and, hence, endow nanoparticles with a unique tumor-targeting ability.